Why Zomedica Stock Dropped Today
Shares of Zomedica (NYSEMKT: ZOM) fell 10.5% Tuesday, furthering the decline in the veterinary health company's stock price over the past week.
Zomedica's shares have shed roughly 28% of their value since the company announced the first sale of its Truforma system on March 16. The diagnostic platform for dogs and cats is Zomedica's first commercial product. Investors have high hopes for its potential to help veterinarians deliver better healthcare to pets -- while fueling Zomedica's revenue and profit growth along the way.
Source Fool.com